Literature DB >> 14522767

Comparison of flap thickness reproducibility using microkeratomes with a second motor for advancement.

Danielle Miranda1, Scott D Smith, Ronald R Krueger.   

Abstract

PURPOSE: To compare flap thickness and reproducibility of four different types of microkeratomes during LASIK.
DESIGN: Retrospective, nonrandomized, comparative case series. PARTICIPANTS: Four hundred ninety consecutive eyes underwent LASIK and were evaluated by measuring the central flap thickness by subtractive pachymetry.
METHODS: All flaps were created using the Bausch & Lomb (Miami, FL) Hansatome 180 head, the Alcon (Fort Worth, TX) Summit Krumeich Barraquer Microkeratome 160 head, the Moria (Antony, France) Carriazo Barraquer (CB) 130 head, or the Moria M2 110 head.
RESULTS: The flap thickness measurements differed according to the microkeratome used and were 131+/-28 microm in 41 eyes (8.4%) with the Bausch & Lomb Hansatome 180 head, 162+/-21 microm in 127 eyes (25.9%) with the Alcon Summit Krumeich Barraquer Microkeratome (SKBM) 160 head, 157+/-40 microm in 65 eyes (13.3%) with the Moria CB 130 head, and 134+/-23 microm in 257 eyes (52.4%) with the Moria M2 110 head. The central flap thickness with the SKBM and Moria M2 was statistically significantly more reproducible than with the Moria CB (P< 0.0005). There is no correlation between flap thickness reproducibility and age, corneal thickness, or corneal keratometric values. However, considering all the microkeratomes, female gender had statistically significantly more variability than male gender (P<0.02).
CONCLUSIONS: Based on these results, the greatest predictability of flap thickness was seen with the SKBM and Moria M2 microkeratomes, which both use a second motor for advancement. The greatest variability, noted with the Moria CB, was likely due to the manual translation feature and places further importance on the safety of the second motor and automation when performing LASIK.

Entities:  

Mesh:

Year:  2003        PMID: 14522767     DOI: 10.1016/S0161-6420(03)00786-3

Source DB:  PubMed          Journal:  Ophthalmology        ISSN: 0161-6420            Impact factor:   12.079


  7 in total

1.  Corneal flap assessment with Rondo microkeratome in laser in situ keratomileusis.

Authors:  Eleftherios I Paschalis; Antonis P Aristeidou; Nikitas C Foudoulakis; Lambros A Razis
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2010-06-25       Impact factor: 3.117

2.  Repeatability of laser in situ keratomileusis flap thickness measurement by Fourier-domain optical coherence tomography.

Authors:  Camila Haydée Rosas Salaroli; Yan Li; Xinbo Zhang; Maolong Tang; José Luiz Branco Ramos; Norma Allemann; David Huang
Journal:  J Cataract Refract Surg       Date:  2011-04       Impact factor: 3.351

3.  Very late-onset flap margin corneal ulcer following laser in situ keratomileusis.

Authors:  Gilad Rabina; Nur Azem; Michael Mimouni; Idan Hecht; David Varssano
Journal:  Int Ophthalmol       Date:  2019-04-13       Impact factor: 2.031

4.  Corneal pachymetry mapping with high-speed optical coherence tomography.

Authors:  Yan Li; Raj Shekhar; David Huang
Journal:  Ophthalmology       Date:  2006-05       Impact factor: 12.079

5.  The safety of 250 microm residual stromal bed in preventing keratectasia after laser in situ keratomileusis (LASIK).

Authors:  Tae Ho Kim; Damho Lee; Hyeon Il Lee
Journal:  J Korean Med Sci       Date:  2007-02       Impact factor: 2.153

6.  Using femtosecond laser to create customized corneal flaps for patients with low and moderate refractive error differing in corneal thickness.

Authors:  Chi Zhang; Jingbin Che; Jianhong Yu; Linli Yu; Dan Yu; Gangping Zhao
Journal:  PLoS One       Date:  2015-03-25       Impact factor: 3.240

7.  A modified risk assessment scoring system for post laser in situ keratomileusis ectasia in topographically normal patients.

Authors:  Mohammad Miraftab; Akbar Fotouhi; Hassan Hashemi; Fatemeh Jafari; Ashkan Shahnazi; Soheila Asgari
Journal:  J Ophthalmic Vis Res       Date:  2014 Oct-Dec
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.